BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32299492)

  • 1. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain.
    Rostami J; Fotaki G; Sirois J; Mzezewa R; Bergström J; Essand M; Healy L; Erlandsson A
    J Neuroinflammation; 2020 Apr; 17(1):119. PubMed ID: 32299492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
    Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
    J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1.
    Williams KC; Dooley NP; Ulvestad E; Waage A; Blain M; Yong VW; Antel JP
    J Neurosci; 1995 Mar; 15(3 Pt 1):1869-78. PubMed ID: 7891140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial reactions in Parkinson's disease.
    McGeer PL; McGeer EG
    Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration.
    Russ K; Teku G; Bousset L; Redeker V; Piel S; Savchenko E; Pomeshchik Y; Savistchenko J; Stummann TC; Azevedo C; Collin A; Goldwurm S; Fog K; Elmer E; Vihinen M; Melki R; Roybon L
    Cell Rep; 2021 Mar; 34(12):108895. PubMed ID: 33761362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes.
    Schiess MC; Barnes JL; Ellmore TM; Poindexter BJ; Dinh K; Bick RJ
    BMC Neurosci; 2010 Nov; 11():151. PubMed ID: 21114836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
    Verma DK; Seo BA; Ghosh A; Ma SX; Hernandez-Quijada K; Andersen JK; Ko HS; Kim YH
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
    Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
    J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading.
    Loria F; Vargas JY; Bousset L; Syan S; Salles A; Melki R; Zurzolo C
    Acta Neuropathol; 2017 Nov; 134(5):789-808. PubMed ID: 28725967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major histocompatibility complex participates in Parkinson's disease.
    Gu R; Pan J; Awan MUN; Sun X; Yan F; Bai L; Bai J
    Pharmacol Res; 2024 May; 203():107168. PubMed ID: 38583689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes.
    Rostami J; Holmqvist S; Lindström V; Sigvardson J; Westermark GT; Ingelsson M; Bergström J; Roybon L; Erlandsson A
    J Neurosci; 2017 Dec; 37(49):11835-11853. PubMed ID: 29089438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
    Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T
    Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.
    Peralta Ramos JM; Iribarren P; Bousset L; Melki R; Baekelandt V; Van der Perren A
    Front Immunol; 2019; 10():80. PubMed ID: 30761145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation.
    Frohman EM; Frohman TC; Dustin ML; Vayuvegula B; Choi B; Gupta A; van den Noort S; Gupta S
    J Neuroimmunol; 1989 Jul; 23(2):117-24. PubMed ID: 2656754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis.
    Mack CL; Vanderlugt-Castaneda CL; Neville KL; Miller SD
    J Neuroimmunol; 2003 Nov; 144(1-2):68-79. PubMed ID: 14597100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains.
    Imamura K; Hishikawa N; Sawada M; Nagatsu T; Yoshida M; Hashizume Y
    Acta Neuropathol; 2003 Dec; 106(6):518-26. PubMed ID: 14513261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.
    Aflaki E; Stubblefield BK; McGlinchey RP; McMahon B; Ory DS; Sidransky E
    Neurobiol Dis; 2020 Feb; 134():104647. PubMed ID: 31669751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and interleukin-1 alpha inhibit through different pathways interferon-gamma-induced antigen presentation, processing and MHC class II surface expression on astrocytes, but not on microglia.
    Gresser O; Hein A; Riese S; Régnier-Vigouroux A
    Cell Tissue Res; 2000 Jun; 300(3):373-82. PubMed ID: 10928267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
    Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
    Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.